Embrace HTA now to survive in the DRG (diagnosis-related group) era, European reimbursement sector told
This article was originally published in Clinica
Executive Summary
Health technology assessment has long been promoted as the tool for medical device manufacturers to gain competitive advantage, but it is increasingly becoming a survival tool as companies jostle for the limited funds that the newly empowered purchasers of healthcare have.